CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00005497
NCT00005497N/ACompleted
CompareCT.gov

Risk Factors for Pulmonary Hypertension of the Newborn

National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated May 13, 2016

In Brief

An observational study for Persistent Fetal Circulation Syndrome and Lung Diseases. Completed.

Detailed Summary

To conduct a multicenter case-control study of persistent pulmonary hypertension of the newborn (PPHN) in relation to maternal exposure to smoking and non-steroidal anti-inflammatory drugs (NSAIDs). Also, to assess other potential antenatal risk factors and collect and store buccal cell specimens for future analyses.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPersistent Fetal Circulation Syndrome, Lung Diseases
Countries--
Collaborators--

Timeline

N/ACompletedFinished
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 26, 2000
Enrollment StartApr 1, 1998
Study CompletionMar 1, 2004
TodayJul 2, 2026
Posted 26.1 years ago